Skip to main content

Table 3 Metabolic parameters and lipid profile at baseline and at 12 months

From: Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children

PATIENT

CHOLESTEROL

HDL-cho

LDL-cho

TG

GLUCOSE

INSULIN

C-PEPTIDE

 

(mg/dl)

(mg/dl)

(mg/dl)

(mg/dl)

(mg/dl)

(IU/ml)

(ng/ml)

 

Values 0–12 m

0–12 m

0–12 m

0–12 m

0–12 m

0–12 m

0–12 m

1

250–182

40–47

179–127

155–36

99–97

8,9–8,4

1,1–1,6

2

192–200

NA – 65

NA – 126

70–41

91–84

4,8–5,2

0,8–1,93

3

338–245

63–69

112–160

112–59

86–94

4,6-NA

0,74-NA

4

325–290

56–61

250–193

92–177

85–86

9,6–8,9

1,8-NA

5

188–152

32–48

133–93

116–92

88–88

9,8–19,4

0,5–0,4

6

120–101

37–35

71–60

60–29

75–78

10–12,3

2,2–1,3

7

195–220

45–52

126–150

118–86

81–85

10–6,9

1,1–1,4

median at baseline

195(120,338)

45(32,63)

129(71,250)

74(60,92)

86(75,99)

9,6(4,6–10)

1,3(0,5–2,5)

median at 12 m

200(101,290)

52(35,69)

127(60,193)

74(29,177)

87(78,97)

8,6(5,2–19,9)

1,4(0,4–1,93

P

0,09

0,04

0,34

0,17

0,4

0,9

0,9

  1. Evolution after switching.
  2. HDL-cho: HDL-cholesterol, LDL-cho: LDL-cholesterol, TG: triglycerides
  3. To convert cholesterol from mg/dl to mmol/l, multiply by 0.0259
  4. To convert triglycerides from mg/dl to mmol/l, multiply by 0.0113
  5. To convert insulin from IU/ml to pmol/l, multiply by 7.175
  6. To convert C-peptide from ng/ml to nmol/l, multiply by 0.33
  7. To convert glucose from mg/dl to mmol/l, multiply by 0.0555